Kelly Patrick F. 4
4 · Forma Therapeutics Holdings, Inc. · Filed Mar 2, 2021
Insider Transaction Report
Form 4
Kelly Patrick F.
SVP, Chief Medical Officer
Transactions
- Award
Stock Option (Right to Buy)
2021-02-26+50,250→ 50,250 totalExercise: $38.61Exp: 2031-02-25→ Common Stock (50,250 underlying) - Award
Common Stock
2021-02-26+16,500→ 16,500 total - Award
Common Stock
2021-02-26+10,670→ 27,170 total
Footnotes (2)
- [F1]These shares represented restricted stock units and will be settled into common stock upon vesting. Each restricted stock unit would be converted into one share of FMTX common stock.
- [F2]25% of the shares subject to the stock option shall vest on February 22, 2022, and the remainder of the shares vest in equal monthly installments for a period of 36 months thereafter.